Indian vaccine majors in talk with Mexico to bolster healthcare

The Serum Institute of India and Bharat Biotech are in talks with the Mexican government for manufacturing vaccines in a deal that will help the two Indian pharmaceutical companies expand their presence in Mexico and the Latin American market.

As part of its efforts to boost its pharmaceutical industry and reduce reliance on imports for critical drugs and vaccines, Mexico is seeking technology collaborations and investments from Indian drug makers.

There are significant advantages to both parties involved in this partnership. Having a presence in Mexico as a strategic hub will allow Indian companies to extend their business operations throughout Latin America.